Discussion Papers

The Incentives for Global Health Discussion Paper series provides informed commentary about how the Health Impact Fund can be developed. We hope they also stimulate conversation and debate on the Health Impact Fund and related topics. The papers in the series will offer a variety of views, many of which may be challenging.

Readers are encouraged to submit comments to the papers' authors. Scholars interested in inclusion in the series are welcome to contact us at igh@yale.edu.

Discussion Paper Number 4. Kalipso Chalkidou, "Assessing the Added Value of Health Technologies: NICE’s Experience in England"

Discussion Paper Number 3. Thomas J. Bollyky, "The Relationship of the Health Impact Fund and Its Registrants"

Discussion Paper Number 2. Talha Syed, "Should a Prize System for Pharmaceuticals Require Patent Protection for Eligibility?"

Discussion Paper Number 1. Aidan Hollis, "The Health Impact Fund and Price Determination"

 

 

© Incentives for Global Health | The Whitney and Betty MacMillan Center for International and Area Studies